Wei Wang

Wei Wang is a Board Certified Toxicologist and currently serves as a Director at Eli Lilly and Company. They have extensive expertise in reproductive and developmental toxicology, endocrinology, and preclinical safety assessments, demonstrated through roles including Senior Study Director at Covance and a postdoctoral fellow at the University of Illinois at Urbana-Champaign. Wei developed significant research contributions, such as a transdermal contraceptive system and in vitro ovarian follicle culture systems for studying endocrine disruptors. They earned a Ph.D. in Physiology from the University of Illinois and are pursuing a Master’s degree in Zoology at Nankai University.